Ovarian Cystadenocarcinoma disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials

Sources

Aliases & Classifications for Ovarian Cystadenocarcinoma

MalaCards integrated aliases for Ovarian Cystadenocarcinoma:

Name: Ovarian Cystadenocarcinoma ¹¹ ¹⁴ ¹⁶ ⁷¹

Cystadenocarcinoma of the Ovary ¹¹

Cystadenocarcinoma of Ovary ¹¹

Classifications:

MalaCards categories:
Global: Cancer diseases
Anatomical: Endocrine diseases Reproductive diseases

See all MalaCards categories (disease lists)

External Ids:

Disease Ontology ¹¹ DOID:3605

NCIt ⁴⁹ C5228

SNOMED-CT ⁶⁸ 314191009

EFO ¹⁶ EFO_1001962

UMLS ⁷¹ C1096638

Sources

Summaries for Ovarian Cystadenocarcinoma

Disease Ontology: ¹¹ An ovary adenocarcinoma that is characterized by the presence of cysts or cystic spaces.

MalaCards based summary: Ovarian Cystadenocarcinoma, also known as cystadenocarcinoma of the ovary, is related to ovarian mucinous cystadenocarcinoma and appendix adenocarcinoma. An important gene associated with Ovarian Cystadenocarcinoma is SERPINA3 (Serpin Family A Member 3), and among its related pathways/superpathways are DNA IR-double strand breaks and cellular response via ATM and Integrated breast cancer pathway. Affiliated tissues include ovary, lymph node and spinal cord, and related phenotypes are neoplasm and muscle

Sources

Related Diseases for Ovarian Cystadenocarcinoma

Diseases related to Ovarian Cystadenocarcinoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 441)

#	Related Disease	Score	Top Affiliating Genes
1	ovarian mucinous cystadenocarcinoma	32.3	SERPINA3 CEACAM5
2	appendix adenocarcinoma	31.6	TP53 KRAS HRAS GNAS CEACAM5
3	cystadenocarcinoma	31.4	TP53 SERPINA3 MIR30A KRAS CEACAM5 BRCA2
4	cystadenoma	30.8	SERPINA3 GNAS CEACAM5 BRCA1
5	ovarian cyst	30.8	GNAS CEACAM5 BRCA1
6	ovarian cystadenoma	30.7	TP53 CEACAM5 BRCA1
7	mucinous cystadenocarcinoma	30.7	SERPINA3 KRAS HRAS CEACAM5
8	bladder urachal carcinoma	30.7	KRAS HRAS
9	serous cystadenocarcinoma	30.6	TP53 MIR30A KRAS HRAS BRCA2 BRCA1
10	adenocarcinoma	30.6	TP53 KRAS HRAS CEACAM5 BRCA2
11	cervical adenocarcinoma	30.6	TP53 KRAS CEACAM5
12	ovarian cancer	30.5	TP53 MIR30A MIR196A1 MIR17 KRAS ICOSLG
13	colonic benign neoplasm	30.5	TP53 SERPINA3 RNF43 KRAS HRAS CEACAM5
14	papillary adenocarcinoma	30.5	TP53 MIR30A KRAS HRAS CEACAM5 BRCA1
15	appendiceal neoplasm	30.5	KRAS HRAS GNAS CEACAM5
16	pseudomyxoma peritonei	30.5	TP53 KRAS GNAS CEACAM5
17	mucinous adenocarcinoma	30.3	U2AF1 TP53 KRAS HRAS GNAS CEACAM5
18	rectum adenocarcinoma	30.3	U2AF1 TP53 SLC25A16 KRAS HRAS CEACAM5
19	endocervical adenocarcinoma	30.3	U2AF1 TP53 SLC25A16 ICOSLG HRAS CEACAM5
20	endometrial cancer	30.2	TP53 MIR30A KRAS HRAS CEACAM5 BRCA2
21	breast adenocarcinoma	30.1	U2AF1 TP53 SERPINA3 KRAS HRAS CEACAM5
22	leiomyosarcoma	30.1	TP53 SERPINA3 BRCA1
23	breast cancer	29.8	TP53 SERPINA3 MIR30A MIR22 MIR196A1 MIR17
24	ovarian serous cystadenocarcinoma	29.6	U2AF1 TP53 SLC25A16 SERPINA3 RNF43 MIR744
25	colorectal cancer	29.6	U2AF1 TP53 SERPINA3 RNF43 MIR483 MIR30A
26	ovary adenocarcinoma	29.1	U2AF1 TP53 SLC25A16 SERPINA3 RNF43 MIR744
27	ovarian clear cell cystadenocarcinoma	11.1
28	mucoepidermoid esophageal carcinoma	10.5	TP53 CEACAM5
29	signet ring basal cell carcinoma	10.5	KRAS CEACAM5
30	blastoma	10.5	TP53 KRAS HRAS
31	carcinosarcoma	10.5	TP53 KRAS HRAS
32	immature teratoma of ovary	10.5	KRAS CEACAM5
33	trachea carcinoma in situ	10.5	KRAS HRAS
34	endometrial mucinous adenocarcinoma	10.5	KRAS GNAS
35	pancreatic foamy gland adenocarcinoma	10.5	TP53 CEACAM5
36	apocrine adenocarcinoma	10.5	TP53 SERPINA3 CEACAM5
37	cholangitis	10.5	TP53 MIR483 CEACAM5
38	syringocystadenoma papilliferum	10.5	SERPINA3 HRAS CEACAM5
39	vaginal carcinosarcoma	10.5	TP53 KRAS HRAS
40	hepatic flexure cancer	10.5	KRAS HRAS CEACAM5
41	descending colon cancer	10.5	KRAS HRAS CEACAM5
42	common bile duct neoplasm	10.5	KRAS HRAS GNAS
43	mucinous intrahepatic cholangiocarcinoma	10.5	KRAS HRAS CEACAM5
44	sigmoid neoplasm	10.5	KRAS HRAS CEACAM5
45	liver angiosarcoma	10.5	TP53 KRAS HRAS
46	malignant spindle cell melanoma	10.5	TP53 SERPINA3 HRAS
47	transverse colon cancer	10.5	KRAS HRAS CEACAM5
48	cystadenofibroma	10.5	TP53 KRAS HRAS
49	malignant spiradenoma	10.5	TP53 CEACAM5
50	ascending colon cancer	10.5	KRAS HRAS CEACAM5

Graphical network of the top 20 diseases related to Ovarian Cystadenocarcinoma:

Sources

Symptoms & Phenotypes for Ovarian Cystadenocarcinoma

MGI Mouse Phenotypes related to Ovarian Cystadenocarcinoma:

⁴⁵

#	Description	MGI Source Accession	Score	Top Affiliating Genes
1	neoplasm	MP:0002006	9.96	BRCA1 BRCA2 CEACAM5 ERCC6 GNAS HRAS
2	muscle	MP:0005369	9.76	BRCA1 CEACAM5 ERCC6 GNAS HRAS KRAS
3	digestive/alimentary	MP:0005381	9.56	BRCA1 BRCA2 CEACAM5 GNAS HRAS KRAS
4	integument	MP:0010771	9.28	BRCA1 BRCA2 ERCC6 GNAS HRAS KRAS

Sources

Drugs & Therapeutics for Ovarian Cystadenocarcinoma

Interventional clinical trials:

#	Name	Status	NCT ID	Phase	Drugs
1	Non-invasive Prenatal Diagnosis (NIPD) of Cystic Fibrosis by Quantitative Real Time MEMO-PCR	Unknown status	NCT02130648

Search NIH Clinical Center for Ovarian Cystadenocarcinoma

Sources

Genetic Tests for Ovarian Cystadenocarcinoma

Sources

Anatomical Context for Ovarian Cystadenocarcinoma

Organs/tissues related to Ovarian Cystadenocarcinoma:

MalaCards : Ovary, Lymph Node, Spinal Cord, Appendix, Breast, Small Intestine, Cervix

Sources

Publications for Ovarian Cystadenocarcinoma

Articles related to Ovarian Cystadenocarcinoma:

(show top 50) (show all 307)

#	Title	Authors	PMID	Year
1	A Rare Case of Low-Grade Serous Cystadenocarcinoma of the Ovary in a Seventeen-Year-Old Woman. ⁶²	Rickards J...Velasquez D	36128000	2022
2	Giant Mucinous Cystadenocarcinoma of the Ovary with Cavitary Metastases to Lungs in a Postmenopausal Woman: A Rare Presentation. ⁶²	Reddy R	35746916	2022
3	Choroidal mass secondary to mucinous cystadenocarcinoma of ovary in a young woman: a life-threatening metastasis. ⁶²	Shariff S...Hitam WHW	34179588	2021
4	A Fatal and Rare Case of Hydatid Cyst in the Pouch of Douglas. ⁶²	Asnani R...Sonkusare S	34149232	2021
5	Primary malignant pericardial tumour in Lynch syndrome. ⁶²	Paolisso P...Galie N	32143595	2020
6	Incidental detection of microfilaria in cyst fluid of Mucinous cystadenocarcinoma of ovary: A rare case report. ⁶²	Vasantham V...Pruthi SK	32416487	2020
7	Early Onset Immune-Related Adverse Event to Identify Pseudo-Progression in a Patient With Ovarian Cancer Treated With Nivolumab: A Case Report and Review of the Literature. ⁶²	Li H...Chen J	32850889	2020
8	Proceedings of the 2019 National Toxicology Program Satellite Symposium. ⁶²	Elmore SA...Wolf JC	31645210	2019
9	Giant ovarian cystadenocarcinoma in an adult patient, a rare finding in modern times. ⁶²	Molina GA...Parra RA	31308929	2019
10	[The morphological and molecular genetic characteristics of nephroblastomas in immature ovarian teratoma in adult patients]. ⁶²	Dolzhansky OV...Pominalnaya VM	31626209	2019
11	The diagnostic challenge of ovarian carcinoma in normal-sized ovaries: a report of two cases. ⁶²	Yong SL...Kang M	30098285	2018
12	[Mucinous cystadenocarcinoma of ovary associated with neuroendocrine carcinoma (Primary ovarian pulmonary-type small cell carcinoma): report of a case]. ⁶²	Qu LM...Ni JS	29783809	2018
13	A computational framework for complex disease stratification from multiple large-scale datasets. ⁶²	De Meulder B...U-BIOPRED Study Group and the eTRIKS Consortium	29843806	2018
14	Mucinous cystadenocarcinoma of the breast: the challenge of diagnosing a rare entity. ⁶²	Koufopoulos N...Khaldi L	29081926	2017
15	Mucinous cystadenocarcinoma of ovary with metastasis in 14-year-old girl. ⁶²	Gupta B...Tempe A	28344967	2017
16	False Positive Diagnosis of Hepatocellular Carcinoma in Liver Resection Patients. ⁶²	Lee H...Suh KS	28049244	2017
17	Cells redox environment modulates BRCA1 expression and DNA homologous recombination repair. ⁶²	Wilson A...Yakovlev VA	27771433	2016
18	IL-27 suppresses SKOV3 cells proliferation by enhancing STAT3 and inhibiting the Akt signal pathway. ⁶²	Zhang Z...Xi M	27639718	2016
19	Association mining of mutated cancer genes in different clinical stages across 11 cancer types. ⁶²	Hu W...Zheng S	27556693	2016
20	Ovarian carcinoma presenting as cutaneous nasal metastasis. ⁶²	Antonio AM...Bartolo E	28300910	2016
21	Giant mucinous cystadenocarcinoma of ovary: A case report and review of literature. ⁶²	Katke RD	27134482	2016
22	Pathology in Practice. Concurrent metastatic mammary adenocarcinoma and ovarian cystadenocarcinoma in a jaguar. ⁶²	Bryan LK...Hoppes SM	26517614	2015
23	"Sea anemone-like ciliated tumor cells" in a case of serous cystadenocarcinoma of the ovary. ⁶²	Handa U...Mohan H	26811576	2015
24	Spontaneous rupture of ovarian cystadenocarcinoma: pre- and post-rupture computed tomography evaluation. ⁶²	Salvadori PS...D'Ippolito G	26543286	2015
25	Extragenital malignant mixed Mullerian tumor in the incisional hernia - primary carcinosarcoma in the abdominal wall: case report. ⁶²	Zuvela M...Milicevic M	26012132	2015
26	Krukenberg carcinoma metastasized from stomach resembling mucinous cystadenocarcinoma of the ovary. ⁶²	Doganay M...Cavkaytar S	26259386	2015
27	A weeping umbilical hernia: bilateral ovarian mucinous cystadenoma with disseminated peritoneal adenomucinosis. ⁶²	Singh VK...Lamichaney R	24855082	2014
28	A 57-year-old Brazilian woman with a giant mucinous cystadenocarcinoma of the ovary: a case report. ⁶²	de Lima SH...Modesto FR	24594205	2014
29	Metastatic ovarian papillary cystadenocarcinoma to the small intestine serous surface: report of a case of high-grade histopathologic malignancy. ⁶²	Khaki F...Abdi FS	24636424	2014
30	Mediastinal recurrence from ovarian cystadenocarcinoma presenting as pleuro-pericardial cyst. ⁶²	Lococo F...Regnard JF	25070811	2014
31	A case of Krukenberg carcinoma metastasized from colon cancer resembling mucinous cystadenocarcinoma of the ovary. ⁶²	Shiono S...Yao T	24427362	2014
32	Evaluation of clinico: pathologic findings of breast carcinoma in a general hospital in Southern India. ⁶²	Mohapatra M...Satyanarayana S	24369200	2013
33	Calcitriol-mediated hypercalcemia: causes and course in 101 patients. ⁶²	Donovan PJ...McLeod DS	23979953	2013
34	Contribution of the PALB2 c.2323C>T [p.Q775X] founder mutation in well-defined breast and/or ovarian cancer families and unselected ovarian cancer cases of French Canadian descent. ⁶²	Tischkowitz M...Tonin PN	23302520	2013
35	Synchronous papillary cystadenocarcinoma of ovary and squamous cell carcinoma of lower vagina: first report of an unusual chance occurrence. ⁶²	Shekhar S...Chander B	23314878	2013
36	IL-17A is elevated in sera of patients with poorly differentiated ovarian papillary serous cystadenocarcinoma. ⁶²	Malekzadeh M...Doroudchi M	24595078	2013
37	A DNA repair pathway-focused score for prediction of outcomes in ovarian cancer treated with platinum-based chemotherapy. ⁶²	Kang J...Kozono D	22505474	2012
38	Human telomerase reverse transcriptase expression in ovarian tumors. ⁶²	Maraei AA...Tan GC	22771641	2012
39	Papillary cystadenocarcinoma of ovary presenting as obstructive jaundice: a rare presentation. ⁶²	Gupta A...Kumar S	22496943	2012
40	Involvement of ARLTS1 in chemotherapy and apoptosis in ovarian cancer cell line. ⁶²	Yang XY...Peng ZL	21153650	2011
41	Testicular papillary serous cystadenocarcinoma: a rare case report and review of the literature. ⁶²	Geramizadeh B...Zeighami S	22355499	2011
42	Hemoperitoneum due to spontaneous rupture of ovarian adenocarcinoma. ⁶²	Casal Rodriguez AX...Brage Gomez S	21221696	2011
43	Consequences of abdominal adenocarcinoma in post-menopausal woman in relation to surgical and non-surgical management. ⁶²	Moniruzzaman M...Mohiuddin T	21863621	2011
44	Malignant mixed Mullerian tumor of broad ligament with synchronous ovarian and endometrial carcinoma: a rare association. ⁶²	Arora P...Tanwar R	21546752	2011
45	Peritoneal Malignant Psammomatous Mesothelioma. ⁶²	Pusiol T...Scialpi M	29147203	2010
46	Ovarian cystadenocarcinoma and pseudomyxoma peritonei. ⁶²	Liu L...Zhang H	22753161	2010
47	Coexistent intramedullary spinal cord and choroidal metastases in ovarian cancer. ⁶²	Kodama M...Takemura M	20178552	2010
48	Histopathologically proven mucinous cystadenocarcinoma metastatic to the choroid. ⁶²	Henderson RH...Hungerford JL	25390397	2010
49	Serous ovarian cystadenocarcinoma incidentally discovered in a 29-year-old patient: case report. ⁶²	Cutura N...Vasiljevic M	21077487	2010
50	Combined chemotherapy with paclitaxel and carboplatin for mucinous cystadenocarcinoma of the ovary during pregnancy. ⁶²	Doi D...Takeshita T	19205713	2009

Sources

Genes for Ovarian Cystadenocarcinoma

Genes related to Ovarian Cystadenocarcinoma (0 elite genes):

(show all 45)

- Elite gene

- Cancer Census gene in COSMIC

#	Symbol	Description	Category	Score	Evidence
1	SERPINA3	Serpin Family A Member 3	Protein Coding	8.05	DISEASES inferred ¹⁴ ¹⁴
2	MIR17	MicroRNA 17	RNA Gene	7.22	DISEASES inferred ¹⁴ ¹⁴
3	MIR744	MicroRNA 744	RNA Gene	7.11	DISEASES inferred ¹⁴ ¹⁴
4	MIR196A1	MicroRNA 196a-1	RNA Gene	6.99	DISEASES inferred ¹⁴ ¹⁴
5	TP53	Tumor Protein P53	Protein Coding	6.68	DISEASES inferred ¹⁴
6	CEACAM5	CEA Cell Adhesion Molecule 5	Protein Coding	6.67	DISEASES inferred ¹⁴
7	KRAS	KRAS Proto-Oncogene, GTPase	Protein Coding	6.59	DISEASES inferred ¹⁴
8	HRAS	HRas Proto-Oncogene, GTPase	Protein Coding	6.57	DISEASES inferred ¹⁴
9	GNAS	GNAS Complex Locus	Protein Coding	6.42	DISEASES inferred ¹⁴
10	MIR101-1	MicroRNA 101-1	RNA Gene	6.41	DISEASES inferred ¹⁴ ¹⁴
11	ICOSLG	Inducible T Cell Costimulator Ligand	Protein Coding	6.35	DISEASES inferred ¹⁴ ¹⁴
12	SLC25A16	Solute Carrier Family 25 Member 16	Protein Coding	6.35	DISEASES inferred ¹⁴
13	MIR483	MicroRNA 483	RNA Gene	6.27	DISEASES inferred ¹⁴ ¹⁴
14	BRCA1	BRCA1 DNA Repair Associated	Protein Coding	6.17	DISEASES inferred ¹⁴
15	MIR30A	MicroRNA 30a	RNA Gene	6.15	DISEASES inferred ¹⁴ ¹⁴
16	U2AF1	U2 Small Nuclear RNA Auxiliary Factor 1	Protein Coding	6.04	DISEASES inferred ¹⁴ ¹⁴
17	RNF43	Ring Finger Protein 43	Protein Coding	5.92	DISEASES inferred ¹⁴
18	MIR22	MicroRNA 22	RNA Gene	5.9	DISEASES inferred ¹⁴ ¹⁴
19	ERCC6	ERCC Excision Repair 6, Chromatin Remodeling Factor	Protein Coding	5.85	DISEASES inferred ¹⁴ ¹⁴
20	BRCA2	BRCA2 DNA Repair Associated	Protein Coding	5.85	DISEASES inferred ¹⁴
21	CTNNB1	Catenin Beta 1	Protein Coding	5.81	DISEASES inferred ¹⁴
22	ERBB2	Erb-B2 Receptor Tyrosine Kinase 2	Protein Coding	5.81	DISEASES inferred ¹⁴
23	PIK3CA	Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Alpha	Protein Coding	5.78	DISEASES inferred ¹⁴
24	PTEN	Phosphatase And Tensin Homolog	Protein Coding	5.78	DISEASES inferred ¹⁴
25	SIGLEC5	Sialic Acid Binding Ig Like Lectin 5	Protein Coding	5.76	DISEASES inferred ¹⁴ ¹⁴
26	H2AC18	H2A Clustered Histone 18	Protein Coding	5.76	DISEASES inferred ¹⁴ ¹⁴
27	AKT1	AKT Serine/Threonine Kinase 1	Protein Coding	5.7	DISEASES inferred ¹⁴
28	EGFR	Epidermal Growth Factor Receptor	Protein Coding	5.69	DISEASES inferred ¹⁴
29	CDKN2A	Cyclin Dependent Kinase Inhibitor 2A	Protein Coding	5.64	DISEASES inferred ¹⁴
30	MUC1	Mucin 1, Cell Surface Associated	Protein Coding	5.62	DISEASES inferred ¹⁴
31	PAX8	Paired Box 8	Protein Coding	5.6	DISEASES inferred ¹⁴
32	CD8A	CD8a Molecule	Protein Coding	5.59	DISEASES inferred ¹⁴
33	MYC	MYC Proto-Oncogene, BHLH Transcription Factor	Protein Coding	5.55	DISEASES inferred ¹⁴
34	SMAD4	SMAD Family Member 4	Protein Coding	5.55	DISEASES inferred ¹⁴
35	GAPDH	Glyceraldehyde-3-Phosphate Dehydrogenase	Protein Coding	5.54	DISEASES inferred ¹⁴
36	CD274	CD274 Molecule	Protein Coding	5.5	DISEASES inferred ¹⁴
37	MUC6	Mucin 6, Oligomeric Mucus/Gel-Forming	Protein Coding	5.49	DISEASES inferred ¹⁴
38	MUC16	Mucin 16, Cell Surface Associated	Protein Coding	5.48	DISEASES inferred ¹⁴
39	ESS2	Ess-2 Splicing Factor Homolog	Protein Coding	5.35	DISEASES inferred ¹⁴
40	ARID1A	AT-Rich Interaction Domain 1A	Protein Coding	5.32	DISEASES inferred ¹⁴
41	ESR1	Estrogen Receptor 1	Protein Coding	5.3	DISEASES inferred ¹⁴
42	CDH1	Cadherin 1	Protein Coding	5.28	DISEASES inferred ¹⁴
43	MUC5AC	Mucin 5AC, Oligomeric Mucus/Gel-Forming	Protein Coding	5.24	DISEASES inferred ¹⁴
44	ACTB	Actin Beta	Protein Coding	5.22	DISEASES inferred ¹⁴
45	CTLA4	Cytotoxic T-Lymphocyte Associated Protein 4	Protein Coding	5.2	DISEASES inferred ¹⁴

Sources

Variations for Ovarian Cystadenocarcinoma

Sources

Expression for Ovarian Cystadenocarcinoma

Search GEO for disease gene expression data for Ovarian Cystadenocarcinoma.

Sources

Pathways for Ovarian Cystadenocarcinoma

Pathways related to Ovarian Cystadenocarcinoma according to GeneCards Suite gene sharing:

(show all 12)

#	Super pathways	Score	Top Affiliating Genes
1	DNA IR-double strand breaks and cellular response via ATM ⁷⁴ Show member pathways ATM pathway ⁶¹ DNA damage_DNA-damage-induced responses ²²	11.68	TP53 BRCA2 BRCA1
2	Integrated breast cancer pathway ⁷⁴	11.64	TP53 KRAS BRCA2 BRCA1
3	BRCA1 Pathway ⁶⁴ Show member pathways Fanconi's Anaemia Pathway ⁶⁴	11.57	TP53 BRCA2 BRCA1
4	DNA IR-damage and cellular response via ATR ⁷⁴	11.54	TP53 BRCA2 BRCA1
5	mTOR Pathway ⁷⁰ Show member pathways TGF-beta Pathway ⁷⁰	11.51	TP53 KRAS HRAS
6	Breast cancer pathway ⁷⁴ Show member pathways Embryonic stem cell pluripotency pathways ⁷⁴	11.45	TP53 KRAS HRAS BRCA2 BRCA1
7	Head and neck squamous cell carcinoma ⁷⁴	11.44	TP53 KRAS HRAS
8	Pathways affected in adenoid cystic carcinoma ⁷⁴	11.34	TP53 HRAS BRCA1
9	Serotonin HTR1 group and FOS pathway ⁷⁴ Show member pathways Serotonin receptor 2 and ELK-SRF/GATA4 signaling ⁷⁴ Serotonin receptor 4/6/7 and NR3C signaling ⁷⁴	11.28	KRAS HRAS GNAS
10	Hepatitis C and hepatocellular carcinoma ⁷⁴	11.17	TP53 MIR744 BRCA1
11	Bladder cancer ⁷⁴	10.73	TP53 KRAS HRAS
12	TNF-alpha signaling pathway ⁷⁴ Show member pathways RAS GTPase cycle mutants ⁶⁶ Signaling by RAS GAP mutants ⁶⁶ Signaling by RAS GTPase mutants ⁶⁶	10.57	KRAS HRAS

Sources

GO Terms for Ovarian Cystadenocarcinoma

Cellular components related to Ovarian Cystadenocarcinoma according to GeneCards Suite gene sharing:

#	Name	GO ID	Score	Top Affiliating Genes
1	RISC complex	GO:0016442	9.73	MIR744 MIR30A MIR22 MIR196A1 MIR17 MIR101-1
2	nuclear ubiquitin ligase complex	GO:0000152	9.46	BRCA2 BRCA1
3	extracellular vesicle	GO:1903561	8.92	MIR30A MIR22 MIR17 MIR101-1

Biological processes related to Ovarian Cystadenocarcinoma according to GeneCards Suite gene sharing:

#	Name	GO ID	Score	Top Affiliating Genes
1	miRNA-mediated gene silencing	GO:0035195	9.93	MIR101-1 MIR17 MIR196A1 MIR22 MIR30A MIR483
2	cellular response to ionizing radiation	GO:0071479	9.85	TP53 BRCA2 BRCA1
3	intrinsic apoptotic signaling pathway in response to DNA damage	GO:0008630	9.83	ERCC6 BRCA2 BRCA1
4	response to gamma radiation	GO:0010332	9.73	TP53 ERCC6 BRCA2
5	positive regulation of gene expression	GO:0010628	9.65	TP53 MIR17 MIR101-1 KRAS HRAS ERCC6
6	chordate embryonic development	GO:0043009	9.58	BRCA2 BRCA1
7	negative regulation of cell migration involved in sprouting angiogenesis	GO:0090051	9.5	MIR483 MIR22 MIR196A1
8	response to X-ray	GO:0010165	9.1	TP53 ERCC6 BRCA2

Molecular functions related to Ovarian Cystadenocarcinoma according to GeneCards Suite gene sharing:

#	Name	GO ID	Score	Top Affiliating Genes
1	mRNA 3'-UTR binding	GO:0003730	9.43	TP53 MIR483 MIR30A MIR17 MIR101-1
2	mRNA base-pairing translational repressor activity	GO:1903231	9.1	MIR483 MIR30A MIR22 MIR196A1 MIR17 MIR101-1

Sources

Sources for Ovarian Cystadenocarcinoma

¹ BitterDB

² CDC

³ Cell Signaling Technology

⁴ ClinicalTrials

⁵ ClinVar

⁶ CNVD

⁷ Cochrane Library

⁸ Cosmic

⁹ dbSNP

¹⁰ DGIdb

¹¹ Disease Ontology

¹² diseasecard

¹³ DiseaseEnhancer

¹⁴ DISEASES

¹⁵ DrugBank

¹⁶ EFO

¹⁷ ExPASy

¹⁸ FMA

¹⁹ GARD

²⁰ GeneAnalytics

²¹ GeneCards

²² GeneGo (Thomson Reuters)

²³ GeneHancer via GeneCards

²⁴ GeneReviews

²⁵ GenomeRNAi

²⁶ GEO DataSets

²⁷ GO

²⁸ GTR

²⁹ HMDB

³⁰ HPO

³¹ ICD10

³² ICD10 via Orphanet

³³ ICD11

³⁴ ICD9CM

³⁵ IUPHAR

³⁶ LifeMap

³⁷ LncRNADisease

³⁸ LOVD

³⁹ MalaCards

⁴⁰ MedGen

⁴¹ MedlinePlus

⁴² MedlinePlus Genetics

⁴³ MeSH

⁴⁴ MESH via Orphanet

⁴⁵ MGI

⁴⁶ miR2Disease

⁴⁷ NCBI Bookshelf

⁴⁸ NCI

⁴⁹ NCIt

⁵⁰ NDF-RT

⁵¹ NIH Clinical Center

⁵² NINDS

⁵³ Novoseek

⁵⁴ Novus Biologicals

⁵⁵ ODiseA

⁵⁶ OMIM via Orphanet

⁵⁷ OMIM® (Updated 08-Dec-2022)

⁵⁸ Orphanet

⁵⁹ PathCards

⁶⁰ PharmGKB

⁶¹ PubChem

⁶² PubMed

⁶³ PubMed Health

⁶⁴ QIAGEN

⁶⁵ R&D Systems

⁶⁶ Reactome

⁶⁷ Sino Biological

⁶⁸ SNOMED-CT

⁶⁹ SNOMED-CT via HPO

⁷⁰ Tocris

⁷¹ UMLS

⁷² UMLS via Orphanet

⁷³ UniProtKB/Swiss-Prot

⁷⁴ WikiPathways

⁷⁵ Wikipedia

MCID: OVR047 MIFTS: 38	Ovarian Cystadenocarcinoma Categories: Cancer diseases, Endocrine diseases, Reproductive diseases	Data Licensing For inquiries, contact: [email protected]
Genes Tissues Related diseases Publications Expand all tables